Syngene International Limited

Syngene International Limited

Syngene International Limited has informed the Exchange regarding the resignation of Mr. Peter Bains as Managing Director & Chief Executive Officer, effective June 30, 2026.

Syngene International Limited

Syngene International Limited has informed the Exchange about the publication of a newspaper advertisement regarding the Notice of the 33rd Annual General Meeting and Annual Report for FY 2025-26.

Syngene International Limited

Syngene International Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on July 29, 2026. The meeting will consider and approve the appointment of Professor Catherine Rosenberg as Director, adoption of audited financial statements, and declaration of a final dividend of `1.25 per equity share for the Financial Year ended March 31, 2026. The meeting will also consider the appointment of S. R. Batliboi & Associates LLP as the Statutory Auditors of the Company.

Syngene International Limited

Syngene International Limited has announced the appointment of Siddharth Mittal as the Managing Director and Chief Executive Officer of the company, effective July 1, 2026. Mittal succeeds Peter Bains, who completed his tenure as Managing Director & CEO on June 30, 2026. Mittal brings close to three decades of business leadership experience, having held various positions at Biocon Limited, including Chief Financial Officer and Managing Director & CEO.

Syngene International Limited

Syngene International Limited has informed the Exchange about the intimation of the 33rd Annual General Meeting, record date, and final dividend information.

Syngene International Limited

Syngene International Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Syngene International Limited

Syngene International Limited has informed the Exchange about Email communication sent to Shareholders - TDS on Final Dividend. The company has recommended a final dividend at the rate of 12.50% for the Financial Year ended March 31, 2026, subject to the approval of shareholders at the ensuing 33rd Annual General Meeting scheduled to be held on July 29, 2026.

Syngene International Limited

Syngene International Limited has submitted the voting results and scrutinizer's report for its recent Postal Ballot. Shareholders approved, via a Special Resolution, the change in the role of Ms. Kiran Mazumdar-Shaw from Non-Executive Chairperson to Executive Chairperson. This decision signifies a key shift in the company's leadership structure, bringing its founder into a more active executive capacity. Investors should note this governance change and its potential implications for the company's strategic direction and operational oversight.